Categories: Health

Enovis to Participate in Upcoming Investor Conferences

 | Source: Enovis Corporation

Wilmington, DE, June 06, 2025 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:

  • Goldman Sachs 46th Annual Global Healthcare Conference: Ben Berry, Chief Financial Officer, will participate in a fireside chat on Tuesday, June 10th at 2:00 p.m. Eastern Time.
  • Citizens Medical Devices and Healthcare Services Forum: Ben Berry, Chief Financial Officer, will participate in investor meetings on Tuesday, June 17th.

A link to the live audio webcasts, if available, as well as a replay of these events, will be available on the Company’s website under the Investors tab at Events and Presentations.

ABOUT ENOVIS

Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.

Contact:

Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com

GlobeNews Wire

Recent Posts

Commure Introduces Dictation: AI-Powered Clinical Voice, Now at the Cursor

MOUNTAIN VIEW, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Commure today announced Commure Dictation, a…

2 minutes ago

Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium

April 02, 2026 08:00 ET  | Source: Tvardi Therapeutics HOUSTON, April 02, 2026 (GLOBE NEWSWIRE)…

2 minutes ago

Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment

KNOXVILLE, Tenn., April 02, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”)…

2 minutes ago

Wix Announces Preliminary Results of Modified Dutch Auction Tender Offer

NEW YORK, April 2, 2026—Wix.com Ltd. (Nasdaq: WIX) (“Wix” or the “Company”) today announced the…

1 hour ago

Aurora Mobile Unveils 500% Efficiency Boost Case Study at Tourism Web3 Summit 2026

SINGAPORE, April 02, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or…

1 hour ago

L3Harris Selects Mercury To Provide Solid-State Data Recorders for SDAs Tranche 3 Tracking Layer Satellites

ANDOVER, Mass., April 02, 2026 (GLOBE NEWSWIRE) -- Mercury Systems, Inc. (NASDAQ: MRCY, www.mrcy.com), a global…

1 hour ago